
Moderna Inc. (NASDAQ:MRNA) shares are trading lower Monday.
A recent CDC study showed protection from COVID-19 booster doses can wane after four months. Moderna investors are also expressing concerns about recent stock sales from Moderna CEO Stéphane Bancel, as well as the deletion of his Twitter account.